These data support the notion that metabolically activated MMe-like PBMC phenotype in T2DM are associated with increased levels of CD68, IL-6, iNOS, TNFα, CD206, and CD36 and decreased levels of CD11b, CD163, CD11c, CD169. Here, ITGAX is linked to type 2 diabetes mellitus.